Exploring Hematological Parameters and Their Prognostic Value in Adult COVID-19 Patients: Insights from Mogadishu, Somalia

Table 4

Hematological characteristics of study participants.

Parameters	N %	COVID-19 status
		SCP	NSCP
Hemoglobin
Anemic	273 (63.0)	245 (63.6)	28 (58.3)
Polycythemia	69 (15.9)	62 (16.1)	7 (10.0)
Normal	91 (21.0)	78 (20.3)	13 (27.1)
Erythrocyte
Low	217 (50.1)	194 (50.4)	23 (47.9)
Erythrocytosis	132 (30.5)	118 (30.6)	14 (29.2)
Normal	84 (19.4)	73 (19.0)	11 (22.9)
Hematocrit
Low	271 (62.6)	244 (63.4)	27 (56.3)
High	81 (18.7)	70 (18.2)	11 (22.9)
Normal	81 (18.7)	71 (18.4)	10 (20.8)
Mean cell volume
Microcytic	69 (15.9)	61 (15.8)	8 (16.7)
Macrocytic	46 (10.6)	40 (10.4)	6 (12.5)
Normocytic	318 (73.4)	284 (73.8)	34 (70.8)
Leukocyte
Leukopenia	124 (28.6)	111 (89.5)	13 (10.5)
Leukocytosis	32 (7.4)	29 (90.6)	3 (9.4)
Normal	277 (63.9)	245 (88)	32 (11.6)
Neutrophil
Neutropenia	11 (2.5)	7 (63.6)	4 (36.4)
Neutrophilia	323 (74.6)	288 (89)	35 (10.8)
Normal	99 (22.9)	90 (90.9)	9 (9)
Lymphocyte
Lymphopenia	341 (78.8)	296 (86.8)	45 (13.2)
Lymphocytosis	38 (8.8)	35 (92.1)	3 (7.9)
Normal	54 (12.5)	48 (88.9)	6 (11.1)
Monocyte
Monocytopenia	14 (3.2)	11 (78.6)	3 (21.4_
Monocytosis	57 (13.2)	30 (52.6)	27 (50.9)
Normal	359 (82.9)	341 (94.9)	18 (5)
Eosinophil
Eosinopenia	46 (10.6)	42 (91.3)	4 (8.7)
Eosinophilia	15 (3.5)	1386.7)	2 (13.3)
Normal	372 (85.9)	330 (88.7)	42 (11.3)
Basophil
Basopenia	20 (4.6)	8 (40)	12 (60)
Basophilia	24 (5.5)	21 (95.8)	3 (12.5)
Normal	389 (89.8)	356 (91.5)	33 (8.5)
Thrombocyte
Thrombocytopenia	18 (4.2)	12 (66.7)	6 (33.3)
Thrombocytosis	37 (8.5)	37 (100)	0 (0)
Normal	378 (87.3)	336 (88.9)	42 (11.1)